We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Device-Drug Interaction Fuels Debate Over Plavix Treatment
Device-Drug Interaction Fuels Debate Over Plavix Treatment
January 3, 2007
Patients implanted with drug-eluting stents who have not had cardiovascular events or additional procedures within six months of follow-up may benefit from extended use of the blood-thinning drug clopidogrel, according to a study to be published in the Jan. 10 issue of The Journal of the American Medical Association (JAMA).